Institutional investors purchased a net $553.3 thousand shares of JNP during the quarter ended September 2015 and now own 33.66% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MORGAN STANLEY & CO. LLC Bought 180.7 Thousand shares of Juniper Pharmaceuticals I...
EAM INVESTORS LLC Bought 145.9 Thousand shares of Juniper Pharmaceuticals I...